Skip to content

Health-related Quality of Life and Psychosocial Aspects of Diabetes Technology (Insulin Pumps)

Aspects of Diabetes Technology (Insulin Pumps) Children Perspective, a Cross - Sectional Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04756011
Enrollment
60
Registered
2021-02-16
Start date
2020-03-15
Completion date
2021-02-01
Last updated
2021-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Related Quality of Life, Insulin Pump, T1DM

Keywords

Insulin pump, T1DM, HRQL

Brief summary

This study will be prospective comparative trial comparing between insulin pumps vs Multiple daily injections (MDI) in treatment of type 1 diabetes mellitus (T1DM) in terms of health- related quality of life (HRQL) and efficacy of glycemic control (HbA1c level ) Hypothesis: Type 1 diabetes is characterized by autoimmune destruction of insulin-secreting pancreatic b cells leading to disturbed glucose regulation and overt hyperglycemia which leads to variable consequences and complication. Consequently, individuals with type 1 diabetes have a lifelong dependency on insulin replacement therapy. Aim of the Work: To compare the psychosocial impact of insulin pumps versus multiple daily injections in treatment of type 1 diabetes mellitus (Via questionnaire) in terms of health-related quality of life and efficacy of glycemic control (HbA1c level).

Interventions

OTHERHealth related quality of life

Confidence in diabetes self care questionnaire the socioeconomic level of the family scale MINI-KID the Peds-QL

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* 1.Type 1 diabetes mellitus. * 2.Patients who are on insulin pumps must be for at least 3 months on them

Exclusion criteria

* 1\. Other types of DM e.g., T2DM, MODY. * 2\. Patients with other comorbidities; cardiac, renal, neurological, hepatic ….etc.

Design outcomes

Primary

MeasureTime frameDescription
Confidence in diabetes self care questionnaire (CIDS)10 minthe CIDS scale, assessment included HbA1c, emotional distress, fear of hypoglycemia, self-esteem, anxiety, depression, and self-care behavior. The CIDS scale is a reliable and valid measure of diabetes-specific self-efficacy for use in patients with type 1 diabetes. High psychometric similarity allows for cross-cultural comparisons.
socioeconomic level of the family scale5 minutesAssessment of family socioeconomic standard
MINI-KID (Mini International Neuropsychiatric Interview )25 minutesMini International Neuropsychiatric Interview for Children and Adolescents
Evaluation of health-related quality of life (HRQL)5 minutesHRQL was measured by the Peds-QL 4.0 11,22. The 23-item Peds-QL 4.0 generic core scales encompass (a) physical functioning (eight items), (b) emotional functioning (five items), (c) social functioning (five items), and (d) school functioning (five items). The physical health summary score (eight items) is the same as the physical functioning scale. To create the psychosocial health summary score (15 items), the mean is computed as the sum of the items divided by the number of items answered in the emotional, social, and school functioning scales.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026